Effect of Different Exercises on Quality of Life of Leukemia Patients.

NCT ID: NCT03147365

Last Updated: 2020-07-21

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

75 participants

Study Classification

INTERVENTIONAL

Study Start Date

2017-03-05

Study Completion Date

2020-04-05

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

* To compare between modified strength training program and aerobic exercises on quality of life on children with Acute Lymphoblastic Leukemia.
* To compare between modified strength training program and aerobic exercises on functional capacity on children with Acute Lymphoblastic Leukemia.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

This study will be done to determine any exercise from aerobic exercises or modified strength training program will be more effective on quality of life and functional capacity on children with Acute Lymphoblastic Leukemia .Acute Lymphoblastic Leukemia is wide spread in the world and the children with this disease are fragile so must know the most program effect.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Quality of Life Acute Lymphoblastic Leukemia Exercise

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Experimental controlled randomization using Block Stratified Randomized Software program, after obtaining informed consent from illegible patient or his caregiver.
Primary Study Purpose

OTHER

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Control group

Twenty five children who will not receive any physical therapy treatment.

Group Type NO_INTERVENTION

No interventions assigned to this group

Study group A

Twenty five children who will receive physical therapy treatment which include aerobic exercises.

Group Type EXPERIMENTAL

Aerobic exercises

Intervention Type BEHAVIORAL

Aerobic exercises will do by using treadmill for children of study group A. it will consist of (max.incline15% - max. speed - heart rate grips and wireless chest strap - smooth virtual fitness trainer - smooth drop folding frame - impression shock absorption cushioning system).

Study group B

Twenty five children who will receive physical therapy treatment which include modified strength training program.

Group Type EXPERIMENTAL

Modified strength training

Intervention Type BEHAVIORAL

Dumbbells will be used to conduct the modified strength training program for children of group B. This exercises included five exercises for the main muscle groups: bench press, leg press, seat row, leg extension and lat pull down.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Aerobic exercises

Aerobic exercises will do by using treadmill for children of study group A. it will consist of (max.incline15% - max. speed - heart rate grips and wireless chest strap - smooth virtual fitness trainer - smooth drop folding frame - impression shock absorption cushioning system).

Intervention Type BEHAVIORAL

Modified strength training

Dumbbells will be used to conduct the modified strength training program for children of group B. This exercises included five exercises for the main muscle groups: bench press, leg press, seat row, leg extension and lat pull down.

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Age range from8-12years.
* Children during 3rd phase( maintenance phase of the treatment). According San et al(2007) who found children with Acute Lymphoblastic Leukemia in maintenance phase of treatment can safely perform both aerobic and resistance training .
* Time elapsed since the start of the maintenance phase \>20weeks.
* Children with muscle weakness due to chemotherapy.
* The height , weight and body mass index of the child will take on standard scale.
* preserved cardiac structure and function as assisted by echo-cardiogram.
* The children have ability to walk.

Exclusion Criteria

Children who have one or more of the following criteria will be excluded from the study:

* Receiving more intensive chemotherapy.
* Mental disabled.
* Sever cardiomyopathy (ejection fraction \<40%, ECG will be used as a pretest as it might be a more sensitive tool to exclude angina pectoris).
* Low blood platelet levels (\< 50.000 per µl).
* Marked anemia (hemoglobin \< 8 g/dl).
* Severe cachexia (i.e., weight mass loss \> 35%).
* Pain in bone.
* Inability to walk.
* Sensory disturbance.
* Peripheral neuropathy.
Minimum Eligible Age

8 Years

Maximum Eligible Age

12 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Children's Cancer Hospital Egypt 57357

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Doaa M Khalifa, BSc

Role: PRINCIPAL_INVESTIGATOR

Children's Cancer Hospital Egypt CCHE 57357

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Children's Cancer Hospital Egypt 57357

Cairo, , Egypt

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Egypt

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

CCHE-ALL003

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Fit to Fight Childhood Cancer
NCT05867186 RECRUITING